[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570182":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":41,"collaborators":43,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"First People's Hospital of Hangzhou","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Case Group",null,"This group includes infants and young children diagnosed with Clostridium difficile infection (CDI). Participants in this group have been identified based on medical records andpatient questionnaires showing confirmed CDI diagnosis. This group will be analyzed for epidemiological characteristics and biomarkers associated with CDI.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control Group","This group includes infants and young children without Clostridium difficile infection (CDI). These participants have no record of CDI diagnosis and serve as the control group to identify risk factors and biomarkers by comparing with the case group.",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Li Qian Wang, Master of Medicine","CONTACT","86+18768156110","wanglq921206@163.com",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Hangzhou First People's Hospital","RECRUITING","Hangzhou","Zhejiang, China","310006","China","CN",{"type":31,"coordinates":32},"Point",[33,34],120.16142,30.29365,{"lat":34,"lon":33},[37,39],{"name":38,"role":18,"phone":19,"phoneExt":10,"email":20},"Li Qian Wang, M.Med",{"name":40,"role":18,"phone":10,"phoneExt":10,"email":10},"Jianhua Luo, PHD",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[44],{"name":45,"class":6},"Westlake University","100570182","study-on-clostridium-difficile-infection-in-infants-100570182",false,"NCT06703918","Study on Clostridium Difficile Infection in Infants","A Retrospective Cohort Study on the Epidemiological Characteristics and Biomarkers of Clostridium Difficile Infection in Infants","Inclusion Criteria:\n\n* Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group).\n\nExclusion Criteria:\n\n* Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.","ALL","0 Months","24 Months",{"count":57,"type":58},150,"ESTIMATED","OBSERVATIONAL","This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.",[62],"Clostridium Difficile Infection",[64,65,66,67],"Clostridium difficile","Infants","Epidemiology","Biomarkers","2024-11-21",{"date":70,"type":71},"2024-11-25","ACTUAL",{"date":73,"type":71},"2024-07-01",{"date":75,"type":58},"2026-12-30",{"name":5,"class":6},1]